Biomarker therapy is useful for the detection of genetic alterations during lung cancer and can be used in combination with chemotherapy for improved outcomes in lung cancer patients. It is observed that targeted biomarker therapy increases the average life of the lung cancer patient by 14 to 16 months.
T his exclusive commentary briefs about the importance of biomarkers for lung cancer treatment.
China Reports First Commercial Brain-Computer Interface Implant for Spinal Cord Injury
Anatomy & Physiology
2h ago
50
Rare Triple Procedure Addresses Breast Cancer and Silent Cardiac Disease in One Operation
Cardiology
2h ago
51
What is Your Diagnosis for This Patient with a Painless Lesion on the Tongue?
Oral and Maxillofacial Surgery
8h ago
106
AIIMS Performs Rare Lung Preserving Surgery in Infant With Bilateral CPAM
Anatomy & Physiology
9h ago
245
India Adds Nearly 10,000 MBBS Seats for 2026 to 2027 Academic Session
Allergy & Immunology
9h ago
164
Andhra Pradesh Reports 12 COVID-19 Infections and Four Deaths Between June 26 and July 16
Anesthesiology
14h ago
174
1